Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Indoco Remedies Ltd. Regulatory Filings 2025

Dec 29, 2025

62453_rns_2025-12-29_4c7a4951-ed76-4ba6-aaa0-705be70bf7b1.pdf

Regulatory Filings

Open in viewer

Opens in your device viewer

==> picture [199 x 70] intentionally omitted <==

29[th] December, 2025

To
The Listing Department
National
Stock
Exchange
of
India
Limited
Exchange Plaza,
Bandra – Kurla Complex
Bandra (East)
Mumbai – 400 051
Stock Code : INDOCO
To
The Listing Department
Bombay Stock Exchange Limited
Floor 25, P. J. Towers,
Dalal Street,
Mumbai – 400 001
_Stock Code :_532612

Dear Sir/Madam,

Subject: Intimation of Analyst/ Institutional Investors Meet under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Pursuant to Regulation 30(6) read with Para A of Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the senior management of the Company shall be meeting analysts/investors as follows:-

Date Particulars-
Investor Conference
Type
of
Meeting
Mode of Interaction
18thFebruary, 2026 Dolat Capital Corporate
Conference 2026 -
“Decoding Growth
Strategies”
Group
meeting
Physical Meeting at
Grand Hyatt,
Santacruz, Mumbai

Please note that the details are subject to change. Changes may happen due to exigencies on the part of investors or the Company. No unpublished price sensitive information pertaining to the Company is shared at any of the meets with Analysts/Institutional Investors.

You are requested to kindly take note of the same.

Thanking you, Yours faithfully, For Indoco Remedies Limited

Digitally signed by RAMANATHA RAMANATHAN HARIHARAN N HARIHARAN Date: 2025.12.29 22:18:24 +05'30'

Ramanathan Hariharan Company Secretary & Head Legal

==> picture [593 x 75] intentionally omitted <==